Related references
Note: Only part of the references are listed.KRIT1: A Traffic Warden at the Busy Crossroads Between Redox Signaling and the Pathogenesis of Cerebral Cavernous Malformation Disease
Andrea Perrelli et al.
ANTIOXIDANTS & REDOX SIGNALING (2023)
The interplay of ROS and the PI3K/Akt pathway in autophagy regulation
Lakhan Kma et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2022)
Intranasal lipid nanocarriers: Uptake studies with fluorescently labeled formulations
Elisabetta Muntoni et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2022)
Repurposing of parenterally administered active substances used to treat pain both systemically and locally
Luigi S. Battaglia et al.
DRUG DISCOVERY TODAY (2022)
Editome landscape of CCM-derived endothelial cells
Concetta Scimone et al.
RNA BIOLOGY (2022)
Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM)
Valerio Benedetti et al.
ANTIOXIDANTS (2022)
Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress
Raffaella Mastrocola et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM)
Andrea Perrelli et al.
EXPERT OPINION ON DRUG DELIVERY (2021)
Protein kinase Cα regulates the nucleocytoplasmic shuttling of KRIT1
Elisa De Luca et al.
JOURNAL OF CELL SCIENCE (2021)
Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies
Claudia Pina Costa et al.
ACTA PHARMACEUTICA SINICA B (2021)
A novel insight into differential expression profiles of sporadic cerebral cavernous malformation patients with different symptoms
Hilal Eren Gozel et al.
SCIENTIFIC REPORTS (2021)
Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease
Andrea Perrelli et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Somatic PIK3CA Mutations in Sporadic Cerebral Cavernous Malformations
Matthieu Peyre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Study of Sirolimus Adsorption and Preparation of Its Samples in Methanol, Acetonitrile and Their Mixtures with Water for HPLC-MS/MS Analysis
Artem D. Rogachev et al.
CHROMATOGRAPHIA (2020)
VEGF signalling enhances lesion burden in KRIT1 deficient mice
Peter V. DiStefano et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Dicarbonyl Stress and S-Glutathionylation in Cerebrovascular Diseases: A Focus on Cerebral Cavernous Malformations
Cinzia Antognelli et al.
ANTIOXIDANTS (2020)
KRIT1 loss-mediated upregulation of NOX1 in stromal cells promotes paracrine pro-angiogenic responses
Federica Finetti et al.
CELLULAR SIGNALLING (2020)
Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases
M. Teixeira et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Intracellular Antioxidant Activity of Biocompatible Citrate-Capped Palladium Nanozymes
Mauro Moglianetti et al.
NANOMATERIALS (2020)
Nanoemulsions as Delivery Systems for Poly-Chemotherapy Aiming at Melanoma Treatment
Chiara Dianzani et al.
CANCERS (2020)
Vitamin D Deficiency and the Risk of Cerebrovascular Disease
Hyun Ah Kim et al.
ANTIOXIDANTS (2020)
Redox regulation of tumor suppressor PTEN in cell signaling
Ying Zhang et al.
REDOX BIOLOGY (2020)
Transcriptome analysis provides new molecular signatures in sporadic Cerebral Cavernous Malformation endothelial cells
Concetta Scimone et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Multidisciplinary therapy strategy of precision medicine in clinical practice
Mengjia Qian et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Nanoparticle-Facilitated Delivery of Antioxidant Therapy following Aneurysmal Subarachnoid Hemorrhage
Jacob F. Baranoski et al.
NEUROSURGERY (2019)
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
Fabio Di Domenico et al.
REDOX BIOLOGY (2019)
NRF2 and NF-κB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
Farzane Sivandzade et al.
REDOX BIOLOGY (2019)
Nanoemulsions for Nose-to-Brain Drug Delivery
Maria Cristina Bonferoni et al.
PHARMACEUTICS (2019)
Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways
Jia Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Dual Roles of the AMP-Activated Protein Kinase Pathway in Angiogenesis
Yuanjun Li et al.
CELLS (2019)
Emerging links between cerebrovascular and neurodegenerative diseases-a special role for pericytes
Urban Lendahl et al.
EMBO REPORTS (2019)
KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction
Francesco Vieceli Dalla Sega et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
KRIT1 Loss-Of-Function Associated with Cerebral Cavernous Malformation Disease Leads to Enhanced S-Glutathionylation of Distinct Structural and Regulatory Proteins
Laura Cianfruglia et al.
ANTIOXIDANTS (2019)
Systems-wide analysis unravels the new roles of CCM signal complex (CSC)
Johnathan Abou-Fadel et al.
HELIYON (2019)
Combinatorial Nano-Bio Interfaces
Pingqiang Cai et al.
ACS NANO (2018)
Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery
Luigi Battaglia et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease
Cinzia Antognelli et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Biological Activities, Health Benefits, and Therapeutic Properties of Avenanthramides: From Skin Protection to Prevention and Treatment of Cerebrovascular Diseases
Andrea Perrelli et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Yeast-Derived Recombinant Avenanthramides Inhibit Proliferation, Migration and Epithelial Mesenchymal Transition of Colon Cancer Cells
Federica Finetti et al.
NUTRIENTS (2018)
Data in support of sustained upregulation of adaptive redox homeostasis mechanisms caused by KRIT1 loss-of-function
Cinzia Antognelli et al.
DATA IN BRIEF (2018)
Multifunctional Platinum@BSA-Rapamycin Nanocarriers for the Combinatorial Therapy of Cerebral Cavernous Malformation
Elisa De Luca et al.
ACS OMEGA (2018)
Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways
Lisa A. Lesniewski et al.
AGING CELL (2017)
Expression of angiogenic growth factors VEGF, bFGF and ANG1 in colon cancer after bevacizumab treatment in vitro: A potential self-regulating mechanism
Minjian Zhao et al.
ONCOLOGY REPORTS (2017)
Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium
Luca Goitre et al.
SCIENTIFIC REPORTS (2017)
Clinical Management of Cavernous Malformations
Kelly D. Flemming
CURRENT CARDIOLOGY REPORTS (2017)
Cellular processes underlying cerebral cavernous malformations: Autophagy as another point of view
Saverio Marchi et al.
AUTOPHAGY (2016)
Two is better than one; toward a rational design of combinatorial therapy
Sheng-hong Chen et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2016)
Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1
Helene Choquet et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin
Saverio Francesco Retta et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Platinum nanozymes recover cellular ROS homeostasis in an oxidative stress-mediated disease model
Mauro Moglianetti et al.
NANOSCALE (2016)
Evaluation of the bioactive properties of avenanthramide analogs produced in recombinant yeast
Andrea Moglia et al.
BIOFACTORS (2015)
Regulation of β1 Integrin-Klf2-Mediated Angiogenesis by CCM Proteins
Marc Renz et al.
DEVELOPMENTAL CELL (2015)
Defective autophagy is a key feature of cerebral cavernous malformations
Saverio Marchi et al.
EMBO MOLECULAR MEDICINE (2015)
Phenolic Amides (Avenanthramides) in Oats - A review
Huseyin Boz
CZECH JOURNAL OF FOOD SCIENCES (2015)
PTEN/PI3K/Akt/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations
Souvik Kar et al.
NEUROSURGICAL REVIEW (2015)
Strategy for Identifying Repurposed Drugs for the Treatment of Cerebral Cavernous Malformation
Christopher C. Gibson et al.
CIRCULATION (2015)
Association of Cardiovascular Risk Factors with Disease Severity in Cerebral Cavernous Malformation Type 1 Subjects with the Common Hispanic Mutation
Helene Choquet et al.
CEREBROVASCULAR DISEASES (2014)
Solid lipid nanoparticles as vehicles of drugs to the brain: Current state of the art
Lucia Gastaldi et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
KRIT1 loss of function causes a ROS-dependent upregulation of c-Jun
Luca Goitre et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
KRIT1 Protein Depletion Modifies Endothelial Cell Behavior via Increased Vascular Endothelial Growth Factor (VEGF) Signaling
Peter V. DiStefano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Vasopressin activates Akt/mTOR pathway in smooth muscle cells cultured in high glucose concentration
Daniela K. Montes et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Ultrastructural analysis of vascular features in cerebral cavernous malformations
Gamze Tanriover et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2013)
Complex diseases require complex therapies - Science & Society series on drugs and science
Ravi Iyengar
EMBO REPORTS (2013)
In vitro and in vivo characterization of meloxicam nanoparticles designed for nasal administration
Levente Kuerti et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Kinetic analysis of the toxicity of pharmaceutical excipients cremophor EL and RH40 on endothelial and epithelial cells
Lorand Kiss et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Development of a Physiologically-Based Pharmacokinetic Model for Sirolimus: Predicting Bioavailability Based on Intestinal CYP3A Content
C. Emoto et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Ceria Nanoparticles that can Protect against Ischemic Stroke
Chi Kyung Kim et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery
Luigi Battaglia et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Cerebral cavernous malformations: from genes to proteins to disease Clinical article
Daniel D. Cavalcanti et al.
JOURNAL OF NEUROSURGERY (2012)
Ccm1 Regulates Microvascular Morphogenesis during Angiogenesis
Huiling Liu et al.
JOURNAL OF VASCULAR RESEARCH (2011)
Nitroxyl radical-containing nanoparticles for novel nanomedicine against oxidative stress injury
Toru Yoshitomi et al.
NANOMEDICINE (2011)
Development of Novel Combination Therapies
Janet Woodcock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Injectable Lipid Emulsions-Advancements, Opportunities and Challenges
Ketan Hippalgaonkar et al.
AAPS PHARMSCITECH (2010)
Solubility and Crystal Size of Sirolimus in Different Organic Solvents
Pankaj J. Gandhi et al.
JOURNAL OF CHEMICAL AND ENGINEERING DATA (2010)
Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations
Yuan Zhu et al.
NEUROSURGICAL FOCUS (2010)
Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic review
Peter G. Campbell et al.
NEUROSURGICAL FOCUS (2010)
KRIT1 Regulates the Homeostasis of Intracellular Reactive Oxygen Species
Luca Goitre et al.
PLOS ONE (2010)
Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling
Joycelyn Wuestehube et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Phosphatase and tensin homolog in cerebral cavernous malformation: a potential role in pathological angiogenesis Laboratory investigation
Yuan Zhu et al.
JOURNAL OF NEUROSURGERY (2009)
Cavernous malformations: natural history, diagnosis and treatment
Sachin Batra et al.
NATURE REVIEWS NEUROLOGY (2009)
CD60-Induced Signaling in Human Endothelial Cells Results in mTORC2-and Akt-Dependent Expression of Vascular Endothelial Growth Factor InVitro and In Vivo
Olivier Dormond et al.
JOURNAL OF IMMUNOLOGY (2008)
Susceptibility-weighted imaging in familial cerebral cavernous malformations
Alex D. Cooper et al.
NEUROLOGY (2008)
Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: Efficiency and possible additional pathways
Alexa Klettner et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Susceptibility-weighted Imaging for the evaluation of patients with familial cerebral cavernous malformations: A comparison with T2-weighted fast spin-echo and gradient-echo sequences
J. M. de Souza et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesis
Hendrik Seeliger et al.
CANCER AND METASTASIS REVIEWS (2007)
A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets
WJM Mulder et al.
BIOCONJUGATE CHEMISTRY (2004)
Interaction between krit1 and icap1α infers perturbation of integrin β1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation
J Zhang et al.
HUMAN MOLECULAR GENETICS (2001)
Share Paper
